1. Synthesis and anti-HIV Activity of Sulfated Oligosaccharide-branched beta-CD. Bai, M.X., B. Chaolumen, D. Asai, K. Miyazaki, and T. Yoshida. Journal of Fiber Science and Technology, 2020. 76(1): p. 63-71. ISI[000575751700006].
[WOS]. HIV_10_2020.
2. A Novel HIV-1 Inhibitor That Blocks Viral Replication and Rescues APOBEC3s by Interrupting vif/CBFβ Interaction. Duan, S., S. Wang, Y. Song, N. Gao, L. Meng, Y. Gai, Y. Zhang, S. Wang, C. Wang, B. Yu, J. Wu, and X. Yu. Journal of Biological Chemistry, 2020. 295(43): p. 14592-14605. PMID[32817167]. PMCID[PMC7586213].
[PubMed]. HIV_10_2020.
3. Reactivating Latent HIV with PKC Agonists Induces Resistance to Apoptosis and Is Associated with Phosphorylation and Activation of BCL2. French, A.J., S. Natesampillai, A. Krogman, C. Correia, K.L. Peterson, A. Alto, A.P. Chandrasekar, A. Misra, Y. Li, S.H. Kaufmann, A.D. Badley, and N.W. Cummins. Plos Pathogens, 2020. 16(10): e1008906. PMID[33075109]. [PMC7595626].
[PubMed]. HIV_10_2020.
4. Small Double-stranded RNA with anti-HIV Activity Abundantly Produced by Bacillus subtilis MTCC5480 Isolated from Fermented Soybean. Imrat, R.K. Labala, S. Velhal, S. Bhagat, V. Patel, and K. Jeyaram. International Journal of Biological Macromolecules, 2020. 161: p. 828-835. PMID[32553954].
[PubMed]. HIV_10_2020.
5. Drug Delivery System Targeting CD4(+) T Cells for HIV-1 Latency Reactivation Towards the Viral Eradication. Jaimalai, T., S. Meeroekyai, N. Suree, and P. Prangkio. Journal of Pharmaceutical Sciences, 2020. 109(10): p. 3013-3020. PMID[32593715].
[PubMed]. HIV_10_2020.
6. Using Substrate Envelope to Develop Better HIV-1 Protease Inhibitors. Kerr, E., M. Bhakta, J. Hunter, J. Hernandez, and C. Stelluti. FASEB Journal, 2020. 34. ISI[000546023103448].
[WOS]. HIV_10_2020.
7. Synthesis, Characterization and Biological Activity of Some Dithiourea Derivatives. Odame, F., E. Hosten, J. Krause, M. Isaacs, H. Hoppe, S.D. Khanye, Y. Sayed, C. Frost, K. Lobb, and Z. Tshentu. Acta Chimica Slovenica, 2020. 67(3): p. 764-777. ISI[000574524400009].
[WOS]. HIV_10_2020.
8. Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing Agents. Sorensen, E.S., A.B. Macedo, R.S. Resop, J.N. Howard, R. Nell, I. Sarabia, D. Newman, Y.Q. Ren, R.B. Jones, V. Planelles, A.M. Spivak, and A. Bosque. Antimicrobial Agents and Chemotherapy, 2020. 64(8): e00888-20. PMID[32482680]. PMCID[PMC7526807].
[PubMed]. HIV_10_2020.
9. Effects of Long-term Rapamycin Treatment on SIV Persistence in Rhesus Macaques on Antiretroviral Therapy. Varco-Merth, B., W.B. Brantley, R. Lum, A. Marenco, D.M. Deull, W. Flores, K. Engelman, H. Park, J. Smedley, M.K. Axthelm, J.D. Lifson, L.J. Picker, C. Cameron, T.J. Henrich, and A.A. Okoye. Journal of Medical Primatology, 2020. 49(5): p. 266-266. ISI[000571653100102].
[WOS]. HIV_10_2020.
10. Novel HIV-1 Capsid-targeting Small Molecules of the PF74 Binding Site. Wang, L., M.C. Casey, S.K.V. Vernekar, R.L. Sahani, J. Kankanala, K.A. Kirby, H. Du, A. Hachiya, H. Zhang, P.R. Tedbury, J. Xie, S.G. Sarafianos, and Z. Wang. European Journal of Medicinal Chemistry, 2020. 204: 112626. PMID[32814250]. PMCID[PMC7530112].
[PubMed]. HIV_10_2020.
11. Glycerol Monolaurate, an Analogue to a Factor Secreted by Lactobacillus, Is Virucidal against Enveloped Viruses, Including HIV-1. Welch, J.L., J.H. Xiang, C.M. Okeoma, P.M. Schlievert, and J.T. Stapleton. mBio, 2020. 11(3): e00686-20. PMID[32371599]. PMCID[PMC7201201].
[PubMed]. HIV_10_2020.
12. Anti-HIV/SIV Activity of Icariin and Its Metabolite Anhydroicaritin Mainly Involve Reverse Transcriptase. Xie, Y., L. Xie, A. Chen, S. Wu, Y. Mo, X. Guo, C. Zeng, X. Huang, and J. He. European Journal of Pharmacology, 2020. 884: 173327. PMID[32726656].
[PubMed]. HIV_10_2020.
Patent Citations
13. 2-Imino-5-oxo-imidazolidine Inhibitors of HIV Protease. Cho, A., J.O. Link, and J. Xu. Patent. 2020. 2020-US28336 2020214716: 111pp.
[Patent]. HIV_10_2020.